At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
High sugar low starch diet +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype?
In Brief
A clinical study evaluating High sugar low starch diet and Low sugar high starch diet for Non-alcoholic Fatty Liver Disease (NAFLD). Completed, enrolled 27 participants across 1 site.
Detailed Summary
The hypothesis of this study is that a diet high in sugars will increase abnormalities in blood lipids which are associated with increased cardiovascular disease risk, relative to a diet which is low in sugar. We predict that this potentially adverse effect of dietary sugars on blood lipids will be more pronounced in people with a raised level of stored fat inside their liver, as compared to people with a low level of stored fat.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
CollaboratorsImperial College London, University of Cambridge
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
Primary CompletionAug 2011
Study CompletionSep 2012
First PostedFeb 2013
TodayJul 2026
First PostedFeb 13, 2013
Enrollment StartApr 1, 2009
Primary CompletionAug 1, 2011
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.4 years ago
Interventions
High sugar low starch dietother
Low sugar high starch dietother